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Abstract: Regenerative medicine is an emerging field of the 
healthcare industry that has the potential to treat a myriad of health 
conditions. Induced pluripotent stem cells, human embryonic stem 
cells, and tissue engineering are a few of the treatment methods 
that may be delivered by healthcare professionals in personalized 
medicine. Food and Drug Administration (FDA) approval is 
necessary within the United States before any of these treatment 
options are available. Specific cellular therapies are currently 
undergoing clinical trials and it may be years before approval is 
acquired. The National Institute of Health is proactively working 
to ensure that healthcare policies, costs, regulations, protocols, 
and provisions are implemented to ensure that risks are minimized 
in the case of FDA approval. Regenerative rehabilitation will 
improve traditional healthcare delivery, increasing health, 
function, and quality of life for patients with a variety of conditions.
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Regenerative Medicine
 Throughout the years, medicine has begun to advance at an 
astounding rate. Consequently, these rapid advancements have led to 
emerging and polarizing therapies within the field of regenerative medicine. 
Notably within this sector, stem cell therapies are surfacing that allow 
medical professionals to target and treat the human body in ways that were 
once considered impossible. Hanley, Rastegarlari, and Nathwani (2010) 
discuss the ability of induced pluripotent stem cells and human embryonic 
stem cells to differentiate into every type of cell.  Stem cell capabilities 
reveal that anatomical structures within the body could be regenerated and 
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rehabilitated. Spinal cord injuries, congenital defects, cognitive deficits, 
cardiac disease, anatomical abnormalities and amputations are just some 
of the types of conditions that regenerative medicine could treat and heal. 
Induced pluripotent stem cells will likely focus more on disease treatment 
while embryonic stem cells will concentrate on debilitating injuries and 
degenerative disorders (Hanley, Rastegarlari, Nathwani, 2010). Ethical 
concerns primarily center on the acquisition of human embryonic stem 
cells rather than induced pluripotent stem cells. King and Perrin (2014) 
outline that stem cell opposition regards a human embryo as having moral 
standing because it may form into a human, therefore it would be unethical 
to harm an embryo to harvest stem cells. Despite current opposition, this 
groundbreaking therapy should be fully supported through its infancy 
because the therapeutic use of stem cells possesses the potential to 
revolutionize medicine and rehabilitation.
Regenerative Therapy
 Cellular therapies that focus on the use of stem cells are emerging 
which will allow medical professionals to target and heal injuries and other 
physical conditions. According to the Mayo Clinic (n.d.), rejuvenation, 
replacement, and regeneration are the three interrelated approaches used 
to create and establish effective regenerative medicine for the future. This 
is a dynamic method towards an emerging field of medicine and therapy 
that has the potential to address every physical issue or disability that an 
individual may encounter. For example, stem cells are able to differentiate 
into any somatic cell such as skin cells, brain cells, and lung cells (Mayo 
Clinic, n.d.). According to the National Institute of Biomedical Imaging 
and Bioengineering (2017), an alternative to stem cells for regenerative 
medicine is tissue engineering in which biomaterials are used to develop 
functional tissues through a combination of scaffolding with cells. 
Regenerative medicine is an exciting and emerging field of healthcare that 
has the potential to heal every condition imaginable.
National and Community Healthcare Issue
 Healthcare commonly draws criticism within the United States, 
however few topics within the industry create the polarizing and heated 
discussions as regenerative therapies. Bioethics represent the foundation in 
which regenerative medicine opposition resides, and fear on both a national 
and local level fuels the debates about accessing the benefits of stem cell 
therapy. Stock (2003) acknowledged a variety of fears in healthcare and 
provides an interesting perspective that describes issues and concerns 
surrounding the field of regenerative medicine. Abuse of regenerative 
technologies, philosophical implications based on regenerative therapy, and 
recognizing that we do not control our future even with regenerative medicine 
are three of the fears that were analyzed by Stock (2003). Nationally, the 
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United States would have to regulate and control regenerative technologies
to prevent abuse; it is safe to assume that America is not currently capable 
or prepared to control such a task. Medicine and therapies require the 
implementation of protocols, guidelines, and procedures to minimize risk, 
however since regenerative therapy is an ever-changing and emerging field 
that has not yet attained FDA approval it would be fruitless to create such 
precise provisions.  Locally, fear extends to individuals on a philosophical 
level, it is difficult to predict whether an individual would be able to accept a 
regenerative body part (Stock, 2003). Also, it could in turn make individuals 
question their identity as humans because of the regenerative change they 
will undergo (Stock, 2003). On a long-term global scale, evolution will 
be strongly impacted by the decision made to utilize such a therapy and 
it is unclear what will be achieved because it is currently unknown how 
future technologies will impact self-directed evolution through the use of 
regenerative medicine (Stock, 2003). Deliberation of pros and cons will be 
a continuous and enduring effort of individuals and this nation, however 
the immense benefits to human life and the ever changing nature of humans 
will certainly push regenerative medicine into the practical world.
Delivery of Healthcare
 Contemporary healthcare delivery methods will be implemented 
for regenerative therapy and it will strongly differ from that of traditional 
healthcare delivery. The National Institute of Health examined business 
models and settings in which regenerative medicine could operate. 
Rao (2015) acknowledges that hospital based services and the idea of 
homegrown tissues are two potential therapeutic settings for regenerative 
medicine, and a new stem cell therapy would significantly impact 
healthcare delivery. Rao (2015) acknowledges the inevitable difficulty 
that traditional pharmacological institutes would experience when trying 
to deliver and manufacture regenerative therapies. Regenerative medicine 
is personalized medicine, therefore large manufacturing companies would 
struggle to transition from indirect consumer delivery because they tend 
to the condition and not the individual. The National Institute of Health 
is proactively working to prevent such a delivery issue and is analyzing 
potential solutions for the future of regenerative healthcare delivery (Rao, 
2015). It is important to realize that today’s pharmacological approach 
to healthcare delivery is based on automatic machinery that produces its 
supply of products in bulk for a range of conditions. Alternative settings 
like hospital based services, institutional based services, and home settings 
will work best because individuals are directly tending to their therapeutic 
needs with professional guidance (Rao, 2015). Distributing revolutionary 
regenerative therapies is a difficult proposition since it has never been done, 
ultimately, new and safe delivery methods will emerge to meet its demand.
 Distribution of cell therapy is not the only concern, as healthcare 
delivery also encompasses the application of the therapy for the patient. 
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Silva and Lederman (2004) acknowledge the methods of cellular therapy 
delivery include systemic delivery, local delivery, surgical delivery, 
and catheter delivery. Methods of delivery would be dependent upon 
the patient’s condition, preference, and location. Each delivery method 
possesses their own unique benefits and risks. Systemic delivery would 
be used for cardiovascular application via placement of stem cells within 
intravenous infusion (Silva & Lederman, 2004). Local delivery would take 
place through a needle into the injection site, this would allow for a larger 
and more accurate treatment (Silva & Lederman, 2004). Surgical stem cell 
implantation is a highly targeted method of delivery that would take place 
in high demanding circumstances so that the best results may be obtained 
(Silva & Lederman, 2004). Catheter delivery is an alternative option to the 
previous methods that percutaneously sends stem cells into a region of the 
body (Silva & Lederman, 2004).  Cell therapy has yet to establish itself as 
a reliable and sanctioned method of treatment, it is important to realize that 
these methods of deliveries will evolve and adapt to the demands of patients 
as regenerative medicine evolves in the future.
Impacted Populations
 Various populations of individuals with physical disabilities, 
diseases and injuries would be overwhelmingly impacted by the arrival 
of regenerative therapies. Cellular therapy is an expanding and inclusive 
market that will target specific diseases across a spectrum of illnesses and 
conditions. Syed and Evans (2013) state that in 2011 the stem cell market 
was worth $2.7 billion and projected that in 2016 it would have been worth 
$8.8 billion. While these markets are not based on the United States, they are 
based off of regenerative markets and provide an idea of the impact it would 
have within the United States’ healthcare sector. For example, orthopedic 
injuries regularly involve musculoskeletal structures; these conditions would 
be cured if regenerative medicine were accessible. Greco (2015) outlines 
and focuses on types of arthritis and how this population would utilize 
stem cell therapy to enhance their quality of life. Osteoarthritis, traumatic 
arthritis, and rheumatoid arthritis were highlighted within the article and 
each of these possess structural damage, yet the author discusses instances 
in which experimental use of stem cells improves a participant’s health 
(Greco, 2015). Current surgical treatments include microfracture surgery, 
arthroplasty, osteotomy, and osteochondral autograft transfer system 
surgery. During microfracture surgery, a doctor drills microscopic holes in 
the bone to stimulate inflammation for cartilaginous healing in a localized 
area. Arthroplasty requires a surgeon to reshape bones to reconstruct a 
joint. An osteotomy dictates that a surgeon removes part of a bone, and 
then stabilize the remaining bone with pins to reduce weight bearing on the 
injured area (Greco, 2015). Osteochondral autograft transfer system surgery 
involves moving healthy cartilage to a damaged site to reduce pain (Greco, 
2015). Stem cell therapy would be a desirable alternative to the current 
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traumatic surgical treatments. In theory, any disease could be reversible or 
curable by stem cells, however clinical trials for this therapy are immature 
and need to establish efficacy before being able to reach the broader market.
 Traditional healthcare is a competent method of healthcare delivery 
for a variety of health conditions, however as life evolves newer conditions 
will surface. Emerging cellular therapies offers the opportunity to respond 
to life’s demands while also improving upon the healthcare industry within 
the United States. Personalized medicine via induced pluripotent stem cells, 
human embryonic stem cells, and tissue engineering possesses the ability 
to enhance healthcare delivery. Regenerative rehabilitation is a potentially 
life transforming area of medicine that will rapidly improve one’s quality 
of life while also improving an individual’s ability to complete their daily 
occupations. Regenerative medicine is the next sector of the healthcare 
industry so individuals should currently have professionally administered 
and controlled access to the treatment in order to expedite the FDA approval 
process.
Method
 Academic journals were researched through EBSCOhost and 
Academic Search Complete databases for this literature review. Keywords and 
phrases commonly used included: regenerative, medicine, stem cells, adult 
stem cells, injuries, conditions, target population, therapy, corporatization, 
regenerative medicine practice, and uses of stem cells. Additionally, 
websites with government domains or websites of professionally accepted 
practices were accessed for research. Information was then gathered to be 
analyzed, interpreted, and synthesized for discussion within the article.
Relationship
Healthcare Industry 
 The history of the healthcare industry from the late 1900’s on is 
known as the corporatization era, during this period large companies 
controlled the healthcare scene and instituted the use of advanced technology 
(Shi & Singh, 2015). Regenerative medicine is on the cusp of reaching 
government approval; it could become a dynamic, vital and profitable 
sector of the healthcare industry within America that relies solely on 
advanced technology. Rao (2015) acknowledges that the National Institute 
of Health provides the most research dollars in the United States and that the 
organization is a strong supporter of regenerative medicine. As discussed 
earlier, the traditional healthcare companies may not hold a place in the 
commercialization of regenerative medicine because of the unique nature 
of its delivery, however for those that adapt to the demands of delivery, 
there will be a vast amount of revenue and profit available. Regenerative 
medicine will be an exciting, challenging, polarizing, and profit driven field 
Published by Encompass, 2018
Kentucky Journal of Undergraduate Scholarship, Issue 2, (2018)
48
of medicine that relies on competition to enhance the quality of the product 
for therapeutic use. 
Occupational Science Connection
 Christensen and Townsend (2010) recognize that occupational 
deprivation takes place when an individual is not able to participate in their 
valued occupations for a sustained period of time. Injuries and illnesses 
limit one’s ability to perform daily functions as well as other life functions, 
consequently these individuals will experience a decreased quality of life. 
Occupations are an integral part of one’s life, and without them one’s identity 
and psychosocial processes may become just as impacted as their physical 
deficits. This is another powerful reason that stem cell therapy should be 
considered as a viable treatment for affected individuals. Regenerative 
therapy is dynamic, it extends to all parts of life for individuals and it can 
help eliminate unnecessary occupational injustices that individuals will 
experience throughout their lifetime. 
 Communication is an essential occupation of humans, and without 
it there is an occupational disruption that extends into every interaction 
that one will experience within a given day. Wormal, Fishman, Tolly and 
Birchall (2015) explore how regenerative medicine is being implemented 
in otorhinolaryngology and the potential impact that would take place from 
being able to acutely treat a condition. Communication is frequently disrupted 
with any condition related to otorhinolaryngology so it would be powerful 
to observe successful results in regenerative treatment for one of these 
conditions. Despite the complexity of the circumstances, tissue engineering, 
cellular therapies and other regenerative approaches are targeting many of 
the diseases in this specialty field (Wormal, Fishman, Tolly & Brichall, 
2015). Reestablishing communication after injury or disease would signify 
a significant and monumental moment for regenerative therapy to address 
social participation as a valued occupation.
Connection as a Future Healthcare Provider
 Future healthcare providers will encounter and interact with 
individuals undergoing a stem cell intervention. Therapists must be able to 
provide competent and comprehensive rehabilitation to these individuals 
to ensure their rehabilitation is successfully completed. For example, 
individuals who undergo regeneration of their third phalanx will be relearning 
a skill like writing or typing that they had possessed before the amputation. 
Ambrosio et al. (2010) recognize that stem cells are capable of undergoing 
rehabilitation it is essential that the regenerative and rehabilitative fields 
work in synchronization to ensure that they complement one another for 
high quality future healthcare. Lyons et al. (2009) discussed that stem 
cell rehabilitation is psychologically demanding too because individuals 
undergo a gradual recovery back into their ADL’s and IADL’s. Although
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one may quickly regain a physical function they still must undergo 
rehabilitation and learn to reuse the regenerated body part, this is as 
demanding on the body as it is the mind. There is a myriad of conditions 
that could benefit from regenerative rehabilitation and it is critical that 
clinically relevant strategies are recognized and implemented to ensure that 
individuals are delivered the highest quality of healthcare to improve their 
quality of life.
Relevance
Current Healthcare Policies
 Healthcare policies and cost are a multidimensional topic of 
regenerative medicine that will take some experience to establish into 
effective law and regulation. Creating policies for a therapy still in the 
clinical trial phase is a demanding and difficult task, however there are 
many policies, guidelines, and business models projected with FDA 
approval. French (2016) discusses two different business models projected 
for stem cell therapy. One option is for the patient to pay one sum as if 
it were a surgical operation while the other entertains the idea of making 
annual payments due to the therapy’s unique and time sensitive nature of 
regeneration (French, 2016). Health insurance companies will be needed to 
ensure that healthcare providers are reimbursed for their cellular treatments. 
The most direct route of payment would be the same as treating it like an 
operation, this would prevent the logistical complication of switching 
health insurance plans while making payments during a patient’s stem 
cell intervention.  It will be an interesting debate to follow as regenerative 
medicine progresses through the trial and challenges of the Food and Drug 
Administration. Levine (2008) surveyed stem cell scientists about national 
stem cell policies and through this survey it was verified that the United 
States’ policies are currently considered as too restrictive. Consequently, 
many of these individuals are moving to other countries to study with more 
freedom and autonomy. Overall, policies, guidelines, and cost is currently a 
fluid situation that will require some trial runs to be able and recognize what 
works best for patients and healthcare providers alike.
Implications on Healthcare Delivery
 Personalized medicine through regenerative stem cells is an 
unparalleled treatment and cure for a countless number of diseases, defects, 
disabilities, conditions, and injuries. Pluripotent stem cells are able to 
differentiate into every type of human cell, therefore they have the most 
potential benefits within regenerative medicine. Dr. O’ Brien and Dr. Barry 
(2009) claim that enormous potential has been demonstrated in preclinical 
animal studies, but that early human studies have not been quite as promising. 
Delivery of this pioneering and innovative healthcare will 
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possess unrivaled challenges because there has been no experience within 
the field of rehabilitative regenerative therapy. In theory, every aspect of 
regenerated structures would react as if they were the original structures, 
yet it is unbeknownst how a regenerated structure will handle stress over 
time, how it will develop strength and endurance over time, how it will age 
over time, how to conduct therapy if there were complications, how it will 
react to an injury and numerous other difficulties that may arise. Essentially, 
regenerative structures are ideal on paper, but reality places demands that 
will eventually demonstrate the strengths and weaknesses of regenerating 
human structures. As a future healthcare provider, it would be extremely 
interesting to work in regenerative therapy, and hopefully regenerated 
tissues function as if they were original tissues. Despite the uncertainty, 
any unexpected challenges that arise from regenerative medicine would be 
received and addressed to the best of the ability of a therapist to enhance the 
client’s quality of life
Consequence on Healthcare Delivery
 Risks are inherent with all forms of healthcare delivery, and with a 
groundbreaking field of regenerative therapy emerging the risks are even 
more notorious and prominent. Minimal understanding of such a powerful 
therapy should always be considered a risk itself and it is important that 
it is fully understood before being implemented into practice. Preynant-
Seauve and Karl-Heinz (2011) highlight the infamous complication of 
autoimmune rejection of stem cells in patients. In order to circumvent the 
risk, one can try a immunosuppressant with a similar risk as any organ 
transplant recipient (Preynant-Seauve & Karl-Heinz, 2011) or autograft 
stem cells from themselves; however, the issue surrounding the decision 
to autograft is that an individual will not be able to target genetic diseases 
because their stem cells are susceptible to the same genetic makeup that 
made their condition possible (French, 2016). If this complication were to 
arise, it would need to be immediately addressed or there would risk of 
losing the regenerated body structure, as well as, risk to the patient’s overall 
health and well-being. Healthcare delivery is a dynamic intervention that 
relies on knowledgeable and competent health professionals that are able to 
recognize risks, complications, and progress for their clients.
Conclusion
 Therapeutic intervention through stem cells is a powerful therapy 
that could potentially eliminate illnesses, alleviate injuries, minimize 
chronic conditions and treat a variety of other physical deficits. Bioethical 
debates will continue throughout the years of regenerative medicine’s 
infancy, however there is little debate that humans would minimize such a 
life changing technology. Policies and the delivery of healthcare will evolve 
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and adapt to meet the demands of regenerative medicine as it emerges. 
Occupational injustices will exist as long as physical disabilities, injuries, 
and other conditions prevent individuals from participating in their valued 
occupations; however, regenerative therapy can help reintroduce an 
individual to their occupations, subsequently improving their quality of life. 
This unique type of therapy has implications for healthcare beyond that of 
any modern therapy and it will be interesting to see what emerges in the 
next few years. 
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